These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3732045)

  • 1. Clinical trials in oncology: ethics, errors, methods and results. Proceedings of an international symposium. Villejuif, France, 25-29 June 1984.
    Drugs Exp Clin Res; 1986; 12(1-3):1-298. PubMed ID: 3732045
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethics and errors of clinical trials and the role and place of different types of trial.
    Mathé G; Reizenstein P
    Drugs Exp Clin Res; 1986; 12(1-3):1-9. PubMed ID: 3732046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug trials in pediatric oncology: a multi-facetted problem.
    Boos J
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):613-20. PubMed ID: 9849753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 0 trials: are they ethically challenged?
    Hill TP
    Clin Cancer Res; 2007 Feb; 13(3):783-4. PubMed ID: 17289866
    [No Abstract]   [Full Text] [Related]  

  • 5. The ethical approach to randomization in oncology.
    Arpaillange P; Dion S
    Drugs Exp Clin Res; 1986; 12(1-3):99-103. PubMed ID: 3732058
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trials. Methodologic principles and ethical aspects of treatment evaluation].
    Boivin JM; Alla F
    Rev Prat; 2000 Nov; 50(18):2073-9. PubMed ID: 11192980
    [No Abstract]   [Full Text] [Related]  

  • 7. International clinical trials in radiation oncology. ICTRO. Developmental conference. Paris, France, April 13-16, 1986. Proceedings.
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S1-214. PubMed ID: 3391804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methodology and legitimacy of French clinical trials in primary chemoprevention of cancers. The point of view of the National Federation of French cancer centers].
    Eisinger F; Maraninchi D; Philip T
    Bull Cancer; 1995 Jul; 82 Suppl 3():232s-236s. PubMed ID: 7492838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methodological and ethical difficulties in clinical oncology studies.
    Brera GR; Violato C
    Lancet; 1998 Oct; 352(9137):1391. PubMed ID: 9802305
    [No Abstract]   [Full Text] [Related]  

  • 10. International Symposium on Clinical Pharmacology. Introduction.
    Smahel O
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):3-5. PubMed ID: 4924327
    [No Abstract]   [Full Text] [Related]  

  • 11. [From empiricism to therapeutic trials. Or how statistical methods can contribute to the improvement of therapeutic protocols in cervicofacial oncology].
    Cachin Y; Flamant R; Richard J; Sancho-Garnier H
    Ann Otolaryngol Chir Cervicofac; 1982; 99(1-2):47-52. PubMed ID: 7103330
    [No Abstract]   [Full Text] [Related]  

  • 12. [Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials].
    Shimoyama M; Tajima K
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2507-18. PubMed ID: 8279849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic trials, informed consent. Methodological bases, legal and ethical aspects].
    Bouvenot G; Eschwege E
    Rev Prat; 1994 Dec; 44(20):2767-70. PubMed ID: 7878368
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing accrual in cooperative group clinical trials.
    Demmy TL; Yasko JM; Collyar DE; Katz ML; Krasnov CL; Borwhat MJ; Battershell A; George SL
    J Clin Oncol; 2004 Aug; 22(15):2997-3002. PubMed ID: 15284251
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials symposium. Highlights in development of randomized clinical trials.
    Forbes JF
    Med J Aust; 1981 Feb; 1(4):159-60. PubMed ID: 6939955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of the Symposium on Designs for Clinical Cancer Research. Perspective of the clinician.
    Hoogstraten B
    Cancer Treat Rep; 1980; 64(2-3):537-8. PubMed ID: 7407796
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings of the Symposium on Designs for Clinical Cancer Reseach. Discussion I: Basic design considerations.
    Cancer Treat Rep; 1980; 64(2-3):411-7. PubMed ID: 7407778
    [No Abstract]   [Full Text] [Related]  

  • 18. The ethics of phase 0 oncology trials.
    Abdoler E; Taylor H; Wendler D
    Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled clinical tests].
    Flamant R; Berndt H
    Arch Geschwulstforsch; 1972; 39(2):163-72. PubMed ID: 4557814
    [No Abstract]   [Full Text] [Related]  

  • 20. CT2--the clinical trials control tower: overcoming barriers to opening oncology clinical trials.
    Hammond AL; Waller EK; Finkelstein LB
    J Clin Oncol; 2007 Apr; 25(10):1288; author reply 1288. PubMed ID: 17401022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.